These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 28799258)

  • 1. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
    Kwon Y; Jeon S; Nam S; Shin I
    Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between
    Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
    World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.
    Maehata Y; Nakamura S; Fujisawa K; Esaki M; Moriyama T; Asano K; Fuyuno Y; Yamaguchi K; Egashira I; Kim H; Kanda M; Hirahashi M; Matsumoto T
    Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
    Iguchi M; Kato J; Yoshida T; Yamamoto Y; Nakachi K; Fukatsu K; Mori Y; Maeda Y; Moribata K; Shingaki N; Niwa T; Deguchi H; Inoue I; Maekita T; Tamai H; Ichinose M
    Int J Cancer; 2016 Sep; 139(5):1150-6. PubMed ID: 27083518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients.
    Kwon YH; Heo J; Lee HS; Cho CM; Jeon SW
    Aliment Pharmacol Ther; 2014 Mar; 39(6):609-18. PubMed ID: 24461252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.
    Bae SE; Jung HY; Kang J; Park YS; Baek S; Jung JH; Choi JY; Kim MY; Ahn JY; Choi KS; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Am J Gastroenterol; 2014 Jan; 109(1):60-7. PubMed ID: 24343545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.
    Mori G; Nakajima T; Asada K; Shimazu T; Yamamichi N; Maekita T; Yokoi C; Fujishiro M; Gotoda T; Ichinose M; Ushijima T; Oda I
    Gastric Cancer; 2016 Jul; 19(3):911-8. PubMed ID: 26420267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Metachronous Gastric Cancer Development After Endoscopic Submucosal Dissection for Early Gastric Cancer.
    Ami R; Hatta W; Iijima K; Koike T; Ohkata H; Kondo Y; Ara N; Asanuma K; Asano N; Imatani A; Shimosegawa T
    J Clin Gastroenterol; 2017 Jul; 51(6):494-499. PubMed ID: 27505404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Metachronous Recurrence after Endoscopic Submucosal Dissection of Early Gastric Cancer.
    Chung CS; Woo HS; Chung JW; Jeong SH; Kwon KA; Kim YJ; Kim KO; Park DK
    J Korean Med Sci; 2017 Mar; 32(3):421-426. PubMed ID: 28145644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing metachronous gastric lesions after endoscopic submucosal dissection through Helicobacter pylori eradication.
    Jung S; Park CH; Kim EH; Shin SJ; Chung H; Lee H; Park JC; Shin SK; Lee YC; Lee SK
    J Gastroenterol Hepatol; 2015 Jan; 30(1):75-81. PubMed ID: 25088761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer.
    Kim YI; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Ryu KW; Kim YW
    Helicobacter; 2014 Jun; 19(3):194-201. PubMed ID: 24612125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a multicenter prospective cohort study.
    Hatta W; Koike T; Asonuma S; Okata H; Uno K; Oikawa T; Iwai W; Yonechi M; Fukushi D; Kayaba S; Kikuchi R; Ohyauchi M; Fushiya J; Maejima R; Abe Y; Kawamura M; Honda J; Kondo Y; Dairaku N; Norita K; Watanabe K; Takahashi K; Echigo H; Abe Y; Endo H; Okata T; Hoshi T; Nakamura T; Nakaya N; Iijima K; Masamune A;
    J Gastroenterol; 2023 May; 58(5):433-443. PubMed ID: 36786863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of metachronous gastric cancer after endoscopic submucosal dissection associated with eradication status of Helicobacter pylori.
    Ikeda R; Hirasawa K; Sato C; Sawada A; Nishio M; Fukuchi T; Kobayashi R; Makazu M; Kaneko H; Maeda S
    Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):17-24. PubMed ID: 32483085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Effects of
    Han SJ; Kim SG; Lim JH; Choi JM; Oh S; Park JY; Kim J; Kim JS; Jung HC
    Gut Liver; 2018 Mar; 12(2):133-141. PubMed ID: 29069890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
    J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer.
    Nam SY; Jeon SW; Lee HS; Kwon YH; Park H; Choi JW
    Dig Liver Dis; 2017 May; 49(5):500-506. PubMed ID: 28057446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.